These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 7033528)

  • 21. Multicentre study with a new biphasic oral contraceptive containing ethinylestradiol and desogestrel. Report on efficacy, cycle control and adverse experiences with special emphasis on blood pressure and weight.
    Dieben TO; van Beek A; Coelingh Bennink HJ
    Arzneimittelforschung; 1991 Sep; 41(9):996-8. PubMed ID: 1839126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind comparison of two oral contraceptives containing 50 mu g. and 30 mu g. ethinyl estradiol.
    Dionne P; Vickerson F
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):281-8. PubMed ID: 4208342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinical study of transdermal contraceptive patch in Thai adolescence women.
    Piyasirisilp R; Taneepanichskul S
    J Med Assoc Thai; 2008 Feb; 91(2):137-41. PubMed ID: 18389975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience in Switzerland with the new monophasic oral contraceptive Minulet (75 mcg gestodene, 30 mcg ethinyl oestradiol).
    Privrel T; Daubenfeld O
    Br J Clin Pract; 1988 Jul; 42(7):292-8. PubMed ID: 3075505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Observations with a combined oral contraceptive (Rigevidon) containing minimum oestrogen dose.
    Karsay K
    Ther Hung; 1980; 28(1):17-20. PubMed ID: 7281074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical assessment of a low-oestrogen combined oral contraceptive.
    Bye PG; Elstein M
    Br Med J; 1973 May; 2(5863):389-92. PubMed ID: 4574044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience with a low dose oral contraceptive containing norethisterone and ethinyl oestradiol.
    Morigi EM; Pasquale SA
    Curr Med Res Opin; 1978; 5(8):655-62. PubMed ID: 710178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical trial of a combined oral contraceptive with low estrogen dose (author's transl)].
    Schmidt-Elmendorff HW
    MMW Munch Med Wochenschr; 1975 Feb; 117(9):345-8. PubMed ID: 804642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The first three-stage preparation for hormonal contraception. Clinical results (author's transl)].
    Lachnit-Fixson U
    MMW Munch Med Wochenschr; 1979 Oct; 121(43):1421-6. PubMed ID: 119912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with a modern low-dose gestodene-containing oral contraceptive in adolescents.
    Brill K; Schnitker J; Albring M
    Adv Contracept; 1994 Dec; 10(4):237-47. PubMed ID: 7740990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience with a triphasic oral contraceptive.
    Ulstein M; Svendsen E; Steier A; Bratt H; Fylling P; Lie S; Schiefloe A; Aaserud J
    Acta Obstet Gynecol Scand; 1984; 63(3):233-6. PubMed ID: 6428157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).
    Barbosa IC; Filho CI; Faggion D; Baracat EC
    Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of two biphasic and one triphasic norgestrel/ethinyl estradiol regimens.
    Larrañaga A; Sartoretto JN; Winterhalter M; Navas Filho F
    Int J Fertil; 1978; 23(3):193-9. PubMed ID: 40893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gestodene: clinical experience with an innovative progestogen used in a combination oral contraceptive preparation.
    Merchiers E; Thiery M; Van Kets H; Parewijck W; Defoort P; Martens G
    Acta Ther; 1990; 16(2):129-38. PubMed ID: 12342969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new low-oestrogen, low-progestogen combined oral contraceptive.
    Woutersz TB
    Curr Med Res Opin; 1974; 2(2):95-100. PubMed ID: 4828628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trial of a low dose combined oral contraceptive ('Ovranette').
    Foss GL; Fotherby K
    Curr Med Res Opin; 1975; 3(2):72-6. PubMed ID: 1095309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Planned Parenthood experience with triphasil.
    Hanson MS; Stewart GK; Bechtel RC; Turan ES
    J Reprod Med; 1987 Aug; 32(8):592-6. PubMed ID: 3656299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Four years overall experience with a new low estrogen -- low progestogen oral contraceptive.
    Brat T
    Acta Obstet Gynecol Scand Suppl; 1976; 54():67-70. PubMed ID: 788448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
    Akerlund M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.